Abstract 6: Maternal efficacy, safety, and pregnancy outcomes with degludec versus detemir in the treatment of pregnant women with type 1 diabetes: An international, multicentre, randomised trial

BACKGROUND AND AIMS: To compare the efficacy and safety of insulin degludec (degludec) versus insulin detemir (detemir) in pregnant women with type 1 diabetes (T1D). MATERIALS AND METHODS: EXPECT was an open-label, randomised trial of women aged ≥18 years with T1D and previously treated with insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Balaji, Kamaleswari, Mathiesen1,2, E R, Corcoy3, R, Dunne4, F, Ekelund5, M, Feig6, D S, Hod7, M, Jia5, T, Kalyanam8, B, Kar8, S, Kautzky-Willer9, A, Damm1,2, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Abstracts … Esicon 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067823/
http://dx.doi.org/10.4103/2230-8210.342307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067823/
http://dx.doi.org/10.4103/2230-8210.342307

Ejemplares similares